Breast Cancer News and Research

Latest Breast Cancer News and Research

Researchers identify new regulatory pathway that may play vital role in basal-like breast cancer

Researchers have identified a new regulatory pathway that may play an important role in basal-like breast cancer (BLBC), a particularly aggressive form of breast cancer often referred to as "triple negative." This pathway may serve as a target for the development of an effective therapeutic.

5 Nov 2015

Differences in vitamin D status may account for disparities in breast cancer survival rates

The American Cancer Society just published a paper reporting that while breast cancer incidence rates for 2008-2012 were similar for black and white women, death rates were 42% higher for black women [DeSantis, 2015]. The factors suggested to explain the disparity in mortality rates included difference in stage at diagnosis, obesity, comorbidities, tumor characteristics, as well as access, adherence, and response to treatments.

5 Nov 2015

Higher insulin levels linked to worse prognosis in advanced breast cancer

Patients with breast cancer that has spread to other parts of the body (metastasised) and who have higher insulin levels than normal, but are not diabetic, have a significantly worse prognosis compared with those with normal insulin levels, a researcher will tell the Advanced Breast Cancer Third International Consensus Conference tomorrow (Friday).

5 Nov 2015

Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE technology

Halozyme Therapeutics, Inc. today announced that Janssen Biotech, Inc. has dosed the first patient in a clinical trial evaluating subcutaneous (SC) delivery of daratumumab with Halozyme's proprietary ENHANZE technology in multiple myeloma.

5 Nov 2015

Liquid biopsy provides physicians with up-to-date information about patient's cancer

A team of researchers, including scientists from the Translational Genomics Research Institute, has reported that analyzing circulating tumor DNA (ctDNA) can track how a patient's cancer evolves and responds to treatment.

5 Nov 2015

Drugs that target malignant cells increase life expectancy in advanced breast cancer patients

Clinical studies show that new drugs that target malignant cells of HER2-positive breast cancer, such as Pertuzumab and Trastuzumab Emtansine (T-DM1), increase life expectancy in patients with advanced breast cancer.

5 Nov 2015

CK5 protein marks ovarian cancer likely to be resistant to cisplatin

A University of Colorado Cancer Center study recently published in the International Journal of Gynecological Cancer shows that protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin.

5 Nov 2015

Sanford Research scientists develop animal model to study neurodegenerative disease

Sanford Research scientists have developed a pig model for a neurodegenerative disease that could help better treat the disorder and other physiological conditions. The findings of the project are published in Human Molecular Genetics.

4 Nov 2015

Cancer patients more likely to suffer cognitive impairment, study finds

An international group of researchers has found cancer substantially affects memory, in the largest longitudinal cohort study assessing the impacts of the disease and its treatments on cognitive function.

4 Nov 2015

Tumour DNA in the blood can accurately monitor cancer in real time

Scientists have shown for the first time that tumour DNA shed into the bloodstream can be used to track cancers in real time as they evolve and respond to treatment, according to a new Cancer Research UK study published in the journal Nature Communications today (Wednesday).

4 Nov 2015

Only one in three women in Germany well-informed about mammography screening

Only one in three women participating in Germany's mammography screening programme (MSP) is well-informed about it: the higher the level of education, the greater the chance of women making an informed decision.

4 Nov 2015

OncoSec signs definitive agreements to purchase $7.5 million of securities in registered direct offering

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered into definitive agreements with institutional investors to purchase approximately $7.5 million of securities in a registered direct offering.

4 Nov 2015

Study explores benefits of breast cancer adjuvant therapies

After breast cancer surgery, women are prescribed adjuvant (or follow-up) therapies such as chemotherapy and endocrine drugs to reduce the risk of the cancer returning. It's been assumed that the treatment effects of these therapies remain constant over time, but a new study from the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio suggests the opposite is true.

4 Nov 2015

International research project examines effectiveness of tried and tested medicines for different diseases

The Medical University of Vienna is coordinating an international research project, which investigates the effectiveness of tried and tested medicines for the treatment of some of the heaviest burdens of our modern society including diseases such as cancer, diabetes and cardiovascular diseases. One molecule that these disorders have in common is a receptor known as the calcium-sensing receptor (CaSR), which is the molecular starting point of this project.

4 Nov 2015

New clinical trial uses aggressive treatment method for patients with pancreas cancer

Pancreas cancer remains one of the deadliest cancers worldwide. In the United States, it accounts for only three percent of all diagnosed cancers but it causes almost seven percent of all cancer deaths. A pancreas cancer diagnosis often comes after age 50 and after the cancer has spread, making it difficult to remove surgically.

4 Nov 2015

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

The study showed that about thirty percent to maybe half of the leading causes of death in the world are preventable. These are risk factors that you could manage and thus you could prevent a lot of premature deaths.

3 Nov 2015

Common heart drug may halt progression of angiosarcoma

A common heart drug may stop the progression of angiosarcoma, a cancer of the inner lining of blood vessels, according to a study by researchers at Texas Tech University Health Sciences Center El Paso.

3 Nov 2015

Researchers take new approach to understanding obstacles to breast cancer care in Appalachia

Researchers at the University of Virginia School of Medicine have taken a new approach to understanding why so many breast cancer patients in Appalachia aren't getting the care they need, and their findings are set to change how people view the obstacles to care that beset the region.

3 Nov 2015

New campaign aims to empower African American women to fight against breast cancer

Advocates in seven California cities are expanding a year-long effort to keep African-American women from dying needlessly from breast cancer, with a new statewide campaign aimed at overcoming cultural stereotypes and helping African-American women gain access to mammogram screenings, and into and through treatment if necessary.

3 Nov 2015

Around 20% of ethnic school girls not vaccinated against HPV

Around 20 per cent of girls from ethnic minority backgrounds are not being vaccinated against the Human Papilloma Virus (HPV) because they feel they don't need to have it, according to a Cancer Research UK survey presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool*.

2 Nov 2015

Breast Cancer News and Research

Latest Breast Cancer News and Research

Researchers identify new regulatory pathway that may play vital role in basal-like breast cancer

Differences in vitamin D status may account for disparities in breast cancer survival rates

Higher insulin levels linked to worse prognosis in advanced breast cancer

Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE technology

Liquid biopsy provides physicians with up-to-date information about patient's cancer

Drugs that target malignant cells increase life expectancy in advanced breast cancer patients

CK5 protein marks ovarian cancer likely to be resistant to cisplatin

Sanford Research scientists develop animal model to study neurodegenerative disease

Cancer patients more likely to suffer cognitive impairment, study finds

Tumour DNA in the blood can accurately monitor cancer in real time

Only one in three women in Germany well-informed about mammography screening

OncoSec signs definitive agreements to purchase $7.5 million of securities in registered direct offering

Study explores benefits of breast cancer adjuvant therapies

International research project examines effectiveness of tried and tested medicines for different diseases

New clinical trial uses aggressive treatment method for patients with pancreas cancer

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

Common heart drug may halt progression of angiosarcoma

Researchers take new approach to understanding obstacles to breast cancer care in Appalachia

New campaign aims to empower African American women to fight against breast cancer

Around 20% of ethnic school girls not vaccinated against HPV

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Breast Cancer News and Research

Latest Breast Cancer News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in